Cardiomyocyte Gb 3 clearance which was the primary efficacy endpoint did not reach statistical significance [ 326 ].
2
—
—
The sentences
Greater and highly significant treatment effects were seen in patients that had less severe renal impairment at baseline (eGFR > 55 ml/min/1.73 m 2 ) [ 325 ].